To investigate the possible role of TINT-derived HO-1 in prostate tumors, we examined HO-1 expression both in the Dunning rat prostate cancer model (which included tumors with different aggressiveness) and in patient samples from primary prostate cancers and bone metastases. The gene discussed is HMOX1; the disease is prostate carcinoma.